Does Anyone in America Really Use CEA? Examples from the Field
The resistance to CEA highlighted in Chapters 3–6 suggests that the technique has had little impact. CEA might be characterized as an elegant but forbidden tool, beautifully made but outlawed as too dangerous. Still, the possibility remains that CEA actually enjoys considerable influence, not as an explicit instrument for prioritizing health services, but as a more subtle input into decision making. By the dawn of the 21st century, cost-effectiveness analysts had carved out a distinctive place in mainstream academic American medicine, even as the studies' impacts remained elusive. This chapter describes the possible influence of CEA generally and on major stakeholders, including Medicare, Medicaid, insurance companies, and pharmaceutical companies.
Keywords: health policy, influence of cost-effectiveness, formularies, coverage decisions, insurance companies, pharmaceutical companies
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .